IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines. Sobral MC, Cabizzosu L, Kang SJ, Ruark K, et al. Proc Natl Acad Sci U S A 2024;121:e2322356121.

Read + Share

Amedeo Smart

Independent Medical Education

Sobral MC, Cabizzosu L, Kang SJ, Ruark K, et al. IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines. Proc Natl Acad Sci U S A 2024;121:e2322356121.
PMID: 39556726